Retail news
J&J/Pfizer Selling OTC Zantac
Written by
G
Guest contributorJ&J and Pfizer have agreed to sell the U.S. rights to the over-the-counter version of Zantac to Boehringer Ingelheim.
Back to News
The RetailWire Daily
A daily briefing with the retail news, expert perspective, and business context to bring into your next meeting.
Want to know more? Learn more